| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beam Therapeutics Inc. (BEAM) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. BEAM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 986.7K | $26.89M | - | |
| 10% | 854.6K | $23.29M | - | |
| Pres | 218.4K | $5.95M | - | |
| Other | 109.7K | $2.99M | - | |
| Other | 85.7K | $2.34M | -16,667 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Evans John M.70 | CEO | Sell | 30,000 | $26.75 | $802,483.82 | -1.6% | -26.9% | +1.2% | |
| Jan 2, 2025 | Bellon Christine57 | Chief Legal Officer | Sell | 1,241 | $24.68 | $30,627.88 | -1.2% | -25.2% | +9.9% | |
| Jan 2, 2025 | Cavanagh Bethany J46 | SVP, Finance And Treasurer | Sell | 1,117 | $24.68 | $27,567.56 | -2.5% | -25.2% | +9.9% | |
| Nov 6, 2024 | Ciaramella Giuseppe76 | President | Sell | 51,110 | $26.36 | $1,347,050.05 | -31.9% | -3.3% | -13.0% | |
| Oct 14, 2024 | Ciaramella Giuseppe76 | President | Sale+OE | 51,110 | $26.27 | $1,342,751.70 | -24.2% | -3.9% | -4.4% | |
| Oct 1, 2024 | Bellon Christine57 | Chief Legal Officer | Sell | 385 | $23.48 | $9,039.57 | -0.4% | +7.9% | +3.1% | |
| Oct 1, 2024 | Cavanagh Bethany J46 | SVP, Finance And Treasurer | Sell | 289 | $23.48 | $6,785.46 | -0.6% | +7.9% | +3.1% | |
| Sep 30, 2024 | Evans John M.70 | CEO | Sell | 60,000 | $24.60 | $1,476,024.00 | -6.0% | +3.1% | -0.9% | |
| Jul 2, 2024 | Simon Amy56 | Chief Medical Officer | Sell | 1,250 | $23.28 | $29,094.12 | -0.9% | +8.6% | -11.9% | |
| Jun 27, 2024 | Evans John M.70 | CEO | Sell | 60,000 | $24.50 | $1,470,156.00 | -5.7% | +2.2% | -29.9% |